FDA Undertaking 'New Efforts' on Advisory Committee Disclosures

Drug Industry Daily
KEYWORDS FDA / Rx
A A

The FDA is working on an initiative that will help the public better understand the agency’s conflict-of-interest process for advisory committee members, according to an FDA spokeswoman.

To View This Article:

Login

Subscribe To Drug Industry Daily